Richard Shute

Introduction On May 22nd 2024, I was please to be able to attend an industry roundtable looking at tokenizing the UK’s digital economy. This meeting (agenda and main areas for discussion above) was held on an “interesting” and very wet day in the Palace of Westminster (the beginning of the meeting was delayed and then […]

All-Party Parliamentary Group on Blockchain Technologies : Insights from a ...

 in blog  tagged APPG / blockchain / DeFi / digital identity / DLT / SSI / Web3 by
Photo by Kelly Sikkema on Unsplash (https://unsplash.com/photos/fZirmwarM0E) As businesses get more sizable and more mature they now, inevitably accrete more and more software systems. This estate expansion leads not only to greater complexity and expense for the enterprise, but also to fragmentation, inconsistency and siloing of business processes. Because platform rationalisation and system decommissioning never […]

Software system rationalisation: How to get better outcomes through stronger ...

 in blog  tagged decision-making / decommissioning / informatics / Kano / life science / R&D / rationalisation by
Since the arrival of the Covid-19 pandemic, there has been a huge upsurge in the demand for what is being called “fast science”. Groups around the world are clamoring for data and information on the SARS-CoV-2 virus that causes the disease; not surprisingly they want it as fast as possible. This has led to unprecedented […]

Fast Science, Effective Collaboration and the Need for Trust

 in blog  tagged collaboration / fastscience / quality / reputation / science / speed / trust by
Ever since blockchain burst onto the scene a decade ago as a technology primarily designed for use in the financial services industry, people have continually found new—and sometimes odd—applications for the technology. Blockchain has been applied to everything from “buying” time (sic!) to renting a supercomputer, yet when it comes to the life sciences, a […]

The Future Of Blockchain: The Use Cases Set To Reshape ...

 in blog  tagged API / blockchain / clinical / consent / life science / pharmaceuticals / sharing by
Ahead of Bio-IT World Expo 2019 (#BioIT19), Richard Shute from Curlew Research is interviewed by Bio-IT World on the ever-growing potential for blockchain and distributed ledger technology (DLT) in life sciences. Blockchain has great potential within the clinical arena to support enhanced data management at nearly every level, he maintains. Added to this its potential […]

Blockchain – Not Just For Bitcoin

 in Uncategorized  tagged blockchain / clinical / DLT / healthcare / life science / pharmaceuticals by
In a new article published on LinkedIn, Richard Shute, Curlew Research Consultant, explains why he believes blockchain and distributed ledger technology (DLT) can play a significant role in the good practice areas of the GxP domain to enhance compliance, quality and safety through improved trust and confidence. He explores how this can be accomplished by […]

Blockchain, Distributed Ledger Technology and GxP: The Trust Protocol Enhancing ...

 in blog  tagged blockchain / compliance / GxP / pharmaceuticals / regulatory by